Pharma looking for progress as Brexit talks restart
Pharma hoping for mutual recognition arrangement
Pharma hoping for mutual recognition arrangement
Adrian van den Hoven of Medicines for Europe addresses three big questions facing the biosmilars sector in Europe in 2018.